U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 53

Tests names and labsConditionsGenes, analytes, and microbesMethods

F13A1 Gene Factor XIIIA deficiency NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Genetic Study of Hereditary Thrombophilia (11 genes, 15 variants)

HeartGenetics, Genetics and Biotechnology, SA
Portugal
111
  • E Sequence analysis of select exons
  • T Targeted variant analysis

F13A1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoICU Panel

Centogene AG - the Rare Disease Company
Germany
829848
  • C Sequence analysis of the entire coding region

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics, part of Exact Sciences
United States
346160
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Factor XIII (13) Gene Sequencing (F13A1 and F13B) (2 Day STAT TAT)

Machaon Diagnostics
United States
22
  • C Sequence analysis of the entire coding region

Factor XIIIA deficiency, 613225, Autosomal recessive (Congenital factor XIII deficiency) (F13A1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Venous thrombosis, protection against, 188050, Autosomal dominant (F13A1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Myocardial infarction, protection against, 608446 (F13A1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Fibrinolytic Disorder Panel

Versiti Diagnostic Laboratories Versiti, Inc
United States
39
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Congenital Factor XIII deficiency via the F13A1 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Bleeding Disorders Panel

PreventionGenetics, part of Exact Sciences
United States
7879
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

F13A1 & F13B gene analysis

Molecular Haemostasis & Thrombosis Viapath - Guy's and St. Thomas' NHS Foundation Trust
United Kingdom
22
  • C Sequence analysis of the entire coding region

Coagulation Factor Deficiency Panel

PreventionGenetics, part of Exact Sciences
United States
2120
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hematology Comprehensive Panel 

CGC Genetics Unilabs
Portugal
1291
  • C Sequence analysis of the entire coding region

Bleeding Disorders Panel 

CGC Genetics Unilabs
Portugal
1121
  • C Sequence analysis of the entire coding region

Factor XIII deficiency (sequence analysis of F13A1 gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

Thrombophilia

CGC Genetics Unilabs
Portugal
116
  • C Sequence analysis of the entire coding region

Factor XIII deficiency (deletion/duplication analysis of F13A1 gene)

CGC Genetics Unilabs
Portugal
11
  • D Deletion/duplication analysis

Results: 1 to 20 of 53

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.